Kiromic BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBP and buy or sell other stocks, ETFs, and their options commission-free!About KRBP
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani, CPA
CEOPietro Bersani, CPA
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees—
Employees—
KRBP Key Statistics
Market cap200.00
Market cap200.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume10.40
Average volume10.40
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0445
52 Week high$0.0445
52 Week low—
52 Week low—
Stock Snapshot
The current Kiromic BioPharma(KRBP) stock price is $0.00, with a market capitalization of 200.
On 2026-07-25, Kiromic BioPharma(KRBP) stock opened at —, reached a high of —, and a low of —.
Kiromic BioPharma(KRBP) shares are trading with a volume of 0, against a daily average of 10.4.
People also own
Based on the portfolios of people who own KRBP. This list is generated using Robinhood data, and it’s not a recommendation.